HIV Co-Receptor CCR5: Structure and Interactions with Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3989|9|3|279-288

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.9, Iss.3, 2009-06, pp. : 279-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing clinical role of a CCR5 co-receptor antagonist in HIV-1 infection

By Caldwell David J   Evans Jeffery D  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3231-3242

Informa Healthcare

Access to resources Recommend Favorite

CCR5 inhibitors in HIV-1 therapy

By Dorr Patrick   Perros Manos  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 11, 2008-11 ,pp. : 1345-1361

Informa Healthcare

Access to resources Recommend Favorite

Targeting the CCR5 receptor: a promising approach for HIV

By  

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Advances in HIV-1 Entry Inhibitors: Strategies to Interfere with Receptor and CoReceptor Engagement

By  

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1105-1119

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite